Abstract: Patients admitted to hospital after being diagnosed with fi rst-episode schizophrenia were comprehensively assessed prior to acute treatment (on admission), at the end of the acute treatment (at discharge), and at follow-up after 1 year. The psychopathology was evaluated using the Positive and Negative Syndrome Scale (PANSS). 93 patients were reassessed after 1 year. 73/93 (78%) of the patients fulfi lled the criteria for remission. No statistically signifi cant differences in the total PANSS or subscales scores were found between remitters and nonremitters before or after the fi rst episode treatment. However, non-remitters had a signifi cantly higher total PANSS score after 1 year than remitters. There was no signifi cant difference in mean psychopathology on admission or at discharge, with the exception of items conceptual disorganization, diffi culty in abstract thinking, and lack of judgment and insight between remitters and non-remitters. However, signifi cantly higher mean values were found for all items after 1 year in non-remitters than remitters. On admission the occurrence of positive, negative and general symptoms was balanced; at discharge and after 1 year negative and general symptoms were the most frequently observed. At the 1-year follow-up the impairment of insight and judgment is one of the most frequent symptoms in both remitters (10%) and non-remitters (70%).
Introduction
The diagnosis of schizophrenia is associated with substantial variability between patients with regard to symptoms, treatment response, course, and etiologic risk factor dimension (Arango et al 2004; Keshavan et al 2004) . The early course of schizophrenia, in particular, is highly variable across patients and is not generally well characterized in the literature. It seems that the occurrence of individual symptoms and their dynamics are very important for the outcome, but such a detailed analysis has not, to our knowledge, been published. Some symptoms may be state dependent and vary also in patients with a different outcome.
Our department has been specializing, on a long-term basis, in the problems of fi rst episodes and investigation of individual biological markers of this disease. Since 1996 we have recorded in our databases more than 160 male patients who have been observed longitudinally from the fi rst index hospitalization. The patients are reassessed at 1-, 3-, 5-, and 10-year follow-ups. We evaluate psychopathology, neuropsychological profi le, neuroendocrinology parameters, neurological soft signs, and data from structural and functional neuroimaging methods (Češková et al 2003 Přikryl et al 2006) . The aim of this study was a comparison of temporal changes in psychopathology between remitters and non-remitters at the 1-year follow-up.
Methods
The study was designed as an open, naturalistic, follow-up study. Included in the study were males hospitalized for the first time with the diagnosis first-episode schizophrenia (according to ICD-10 diagnostic criteria for research), who provided written informed consent, and were reassessed at the 1-year follow-up. ICD-10 diagnoses were made on the basis of a comprehensive assessment of symptoms and history, and all other available information about the patients. The diagnosis was confi rmed by consensus of two psychiatrists during separate interviews.
Clinical assessment
The psychopathology was evaluated using the Positive and Negative Syndrome Scale (PANSS, Kay et al 1987) before the acute treatment (on admission), at the end of the acute treatment (at discharge), and at follow-up after 1 year. The patients were divided into remitters and non-remitters when they were reassessed after one year. For remission achievement a score of 3 (mild) or less was required in all eight of the following PANSS items: P1 delusions, P2 conceptual disorganization, P3 hallucinatory behaviour, G5 mannerisms and posturing, G9 unusual thought content, N1 blunted affect, N4 passive/apathetic social withdrawal, N6 lack of spontaneity, and fl ow of conversation for a minimum of 6 months (Kane et al 2003; Andreasen et al 2005) .
Treatment
Most patients were drug-naïve on admission. After a baseline assessment all patients were treated openly by monotherapy with an antipsychotic chosen by the patient's treating clinician and individually dosed. Risperidone was the drug of fi rst choice; other options were selected according to clinical judgment and drug availability. The only concomitant treatments allowed were benzodiazepines for tension, anxiety, and insomnia, and biperidene for extrapyramidal symptoms. After discharge from the index hospitalization the patients were treated as outpatients.
Statistical analysis
The statistical analysis was based on descriptive statistics and nonparametric methods (the Mann-Whitney U test, Wilcoxon matched paired test, chi square test) and performed using STATISTICA software, version 6.
Results

Sample characteristics
93 patients (mean age 23 years, mean duration of illness 0.77 years) were reassessed after 1 year. 73/93 (78%) of the patients fulfi lled the criteria for remission. The average daily dose of antipsychotics during the index hospitalization and at the 1-year follow-up was 228 mg and 127 mg, respectively. 17/93 (18.3%) of the patients had discontinued their medication, the rate of discontinuation was higher in non-remitters 7/20 (35%) than in remitters 10/73 (13.7%) (NS).
Psychopathology-the total PANSS score
No statistically signifi cant differences in the total PANSS or subscales scores were found between remitters and nonremitters before or after the fi rst episode treatment. However, non-remitters had a signifi cantly higher total PANSS score after 1 year than remitters (p < 0.001) (Figure 1 , Table 1 ).
The relative decrease of psychopathology was evaluated using delta PANSS 1 (100 × ( PANSS on admission-PANSS at discharge)/PANSS at discharge). The relative decrease of total psychopathology during the index hospitalization was similar in both remitters ( 38.6%) and non-remitters ( 36.8%). Similar values for delta positive , negative and general PANSS 1 were found for both remitters (50.6%, 27.8%, 35.4%) and non-remitters (52.4%, 25.7%, 32.4%).
After 1 year, there was further relative decrease found in remitters (20.7% ) and a signifi cant increase in non-remitters (-71.0%, p < 0.001 in relation to the end of acute treatment) using delta PANSS 2 (100x (PANSS at discharge-PANSS after 1 year/PANSS after 1 year). Again, similar values were found for delta positive, negative, and general PANSS 2 in both remitters (17.6%, 20.3%, 19.4%) and non-remitters (-97.1%, -86.4%, -61.2%, p < 0.001 in relation to the end of acute treatment) .
Psychopathology-individual PANSS items (mean values)
When the remitters and non-remitters were compared, there was no signifi cant difference in mean psychopathology on admission or at discharge, with the exception of items conceptual disorganization, diffi culty in abstract thinking and lack of judgment and insight. The mean values of these three items were actually lower in non-remitters at discharge. However, signifi cantly higher mean values were found for all items after 1 year in non-remitters than remitters (see Table 2 ) 2.6 (1.1) 2.5 (1.4) 1.9 (0.9) 3.6 (1.5) * N2 emotional withdrawal 3.9 (1.5) 3.4 (1.4) 2.7 (1.0) 2.4 (1.1) 1.9 (0.9) 3.8 (1.6) * N3 poor rapport 3.6 (1.7) 2.9 (1.5) 2.4 (1.1) 2.2 (0.9) 1.7 (0.8) 3.5 (1.5) * N4 passive/apathetic social withdrawal 3.8 (1.7) 3.6 (1.4) 2.5 (1.0) 2.4 (1. Češková et al
Psychopathology-occurrence of individual symptoms (relative values)
A categorical evaluation of individual symptoms was performed during the index hospitalization on admission and at discharge and after 1 year. A minimum score of 4 in the individual items was required for symptom presence.
On admission
Suspiciousness (86%), delusions and lack of judgment and insight (79 %), poor attention (74%), stereotyped thinking (67%), disturbance of volition (65%), conceptual disorganization and active social avoidance (64%) were the most frequently observed symptoms on admission during the acute phase in remitters. Individual negative symptoms were present in about half of the patients. The occurrence of symptoms on admission was similar in non-remitters (Table 2, Figure 2 ).
At discharge
At discharge, the most frequently found symptom in remitters was lack of judgment and insight (46.6%); in non-remitters, blunted affect (25%). Other most frequently observed symptoms were negative and non-specifi c symptoms in both the remitters and non-remitters (Table 2, Figure 3 ).
One-year follow-up
The lack of judgment and insight was the most frequent symptom in both remitters (10%) and non-remitters (70%) at the 1-year follow-up. In contrast to admission, the other most frequently observed symptoms were negative ones (with the exception of delusions) in non-remitters and non-specifi c general symptoms in remitters (Table 2, Figure 4 ).
Discussion
Our data on the occurrence of remission are in accordance with previously published studies. Remission of psychotic symptoms occurred in up to 80% at 1 year (Addington et al 2003; Lieberman et al 2003) . Malla et al (2000) also observed a complete remission rate of 70% in patients with fi rst episode schizophrenia at 1-year follow-up; however, remission was not defi ned according to Andreasen's criteria. In our sample 78% of the patients were remitters and we have found that 18% of the patients discontinued their 
Lack of judgment and insight
First-epidode schizophrenia medication. However, there are some limitations in the interpretation of our results because 25% of the patients invited to participate could not be reached or declined to attend the reassessment after 1 year. Remission achievement and compliance of non-participants is unknown. Patients in the early course of schizophrenia frequently request a decrease or discontinuance of their antipsychotic medications, and many have poor adherence to treatment (Scottish schizophrenia research group 1987). Non-adherence is particularly prominent in fi rst episode patients (Novak-Grubic and Tavcar 1999). In Verdoux's (2000) study the fi rst-admitted subjects with psychosis were assessed at 6-month intervals over a 2-year follow-up period. The proportion of subjects with poor medication adherence ranged from Češková et al Figure 3 The most frequent items at discharge in remitters and non-remitters (%).
Note: symptom presence-score minimally 4 for individual items.
33% to 44% at each follow-up assessment. After successful antipsychotic treatment, many patients believe that they will no longer need medication. Given that the early course of the disorder is highly variable across patients and is generally not well characterized in literature, clinicians are hard put to insist on indefi nite antipsychotic treatment. The role of antipsychotics after the fi rst psychotic manifestation is not fully elucidated. However, medication discontinuation was strongly associated with the worse outcome defi ned in terms of the number of relapses in subjects suffering from fi rst-episode schizophrenia (Robinson et al 1999) . There are also some hints about the neuroprotective role of atypical antipsychotics (Lieberman et al 2003) .
No statistically signifi cant differences in PANSS scores were found between remitters and non-remitters in the acute phase. Given the responsiveness of fi rst-episode patients to treatment, the further course from the fi rst psychotic episode is highly variable and some fi rst-episode patients become more treatment resistant over time. After one year we found that non-remitters had a signifi cantly higher total PANSS score than remitters. This means that the period after a fi rst psychotic manifestation is critical.
Our previous fi ndings concerning acute treatment responsivity showed that in the fi rst psychotic manifestation the most frequently observed symptom was lack of judgment and insight, which persisted at discharge from the index hospitalization. The negative symptoms improved less compared to the positive ones. On admission the responders had higher scores for most symptoms, both positive and negative, than nonresponders (Češková et al 2005) . Similar results were found in this study. Both on admission and at discharge a trend towards a higher score for most symptoms was observed in remitters. The difference in the case of diffi culty in abstract thinking and lack of judgment and insight has reached statistical signifi cance. Thus, there was no signifi cant difference between remitters and non-remitters in the acute phase. However, after 1 year non-remitters had signifi cantly higher mean scores for all PANSS items.
On admission the occurrence of positive, negative, and general symptoms was balanced; at discharge and after 1 year negative and general symptoms were the most frequently observed; at the 1-year follow-up only general, non-specifi c symptoms were observed in remitters. In a methodologically sound study, Peralta (2000) concluded that negative symptoms rated during a fi rst psychotic episode before and after starting antipsychotic treatment are mainly primary in character, and should be considered a direct manifestation of the basic dysfunctions of schizophrenia. Our results are also in agreement with the observation that negative symptoms decrease more slowly than positive ones and may persist in some of the patients. The impairment of insight and judgment was one of the most frequently observed items in both remitters and non-remitters at all three time points. Insight in schizophrenia is important because of its implications for treatment adherence.
The strengths of this study are sample size and homogeneity (males with fi rst-episode schizophrenia, mostly drugnaïve on admission). The fi ndings are limited by the fact that the study was open, performed under routine clinical conditions and 25% of the patients could not be reached or declined to attend the reassessment.
Conclusion
The fi rst episode of schizophrenia is characterized by pronounced treatment response which may not be the case in a portion of patients during the further course of the disease from the fi rst psychotic break-down. After the acute treatment and at 1-year follow-up the most frequent symptoms were negative and non-specifi c general symptoms. At the 1-year follow-up the impairment of insight and judgment is one of the most frequent symptoms in both remitters and non-remitters. This confi rms the suggestion that the period after the fi rst psychotic manifestation constitutes a critical period. Longitudinal follow-up of fi rst-episode patients is of great interest in addressing this question. 
